Thoracoabdominal Artery Stent Graft System Exploratory Study
A legfontosabb adatok
- Ki végzi
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Hol
- Németország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 11 fő, tervezett
- Kezdés
- 2025. júl. 24.
- Várható befejezés
- 2032. jún. 30.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- The system includes the G-Branch™ thoracoabdominal aortic stent graft system, the peripheral vascular stent graft system, and the aortic extension stent graft system
- A regiszteradat frissítve
- 2026. május 26.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a thoracoabdominal aortic aneurysm (a bulge in the main artery across the chest and belly). They will be treated with the G-Branch™ stent graft system placed through the blood vessels.
- Életkor
- 18 to 80 years old
- Nem
- All sexes
- A betegség stádiuma
- Thoracoabdominal aortic aneurysm with at least one of these: widest size >50 mm; growth of more than 5 mm in the past 6 months or more than 10 mm in the past 1 year; clear symptoms such as belly or back pain. The artery sizes and shape must fit the device, and the arteries in the groin and arm must allow access. People who do not want to wait, or cannot wait, for the approved alternative treatment can join.
A részvétel fő kizáró okai
- A burst aneurysm with unstable blood pressure and circulation, an aortic dissection (a tear in the artery wall), or an infected aneurysm
- Blocked gut or kidney arteries, or other infections that could raise the risk of the graft getting infected
- Acute coronary syndrome (heart attack or unstable angina) in the past 6 months, or a stroke or TIA (mini-stroke) in the past 3 months
- ALT or AST > 5 times the upper limit of normal, or serum creatinine >150umol/L (1,7 mg/dL)
- Severe lung problems so that general anesthesia cannot be tolerated
A regiszter feltételei, szó szerint
Mind a 16 feltétel megnézéseKevesebb
Ki vehet részt
- Age: 18 to 80 years old
- Patients diagnosed with a Thoracoabdominal aortic aneurysm (based on the modified Crawford classification and European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms), and should meet at least ONE of the following conditions:; Maximum diameter of TAAA is >50 mm; TAAA diameter increases by more than 5 mm in the past 6 months or by more than 10 mm in the past 1 year; Definite symptoms associated with TAAA, such as abdominal pain and back pain
- Anatomical Criteria; Proximal landing zone (aorta or implanted graft): the diameter ranges from 17 to 36 mm, and length should be ≥25 mm; Distal landing zone (aorta or implanted graft): If distal landing zone is in iliac artery, distal landing zone diameter ranges from 7 to 25 mm, and length should be ≥15 mm; If the distal landing zone is in the abdominal aorta, distal landing zone diameter ranges from 12 to 36 mm, and length should be ≥20 mm; Visceral branch landing zone: the diameter ranges from 6 to 13 mm, and the length should be ≥15 mm; Renal artery landing zone: the diameter ranges from 4.5 to 9 mm, and the length should be ≥15 mm; Appropriate iliac, femoral, and upper limb arterial access
- Patients who understand the purpose of the study, volunteer to participate and sign the informed consent form, and are willing to complete follow-up as required by the protocol
- Patients do not want to or cannot wait for the approved alternative
Ki nem vehet részt
- Patients with ruptured thoracoabdominal aortic aneurysms in unstable hemodynamic condition
- Patients with infected or mycotic thoracoabdominal aortic aneurysms
- Patients with systemic or local infections that may increase the risk of endovascular graft infection
- Patients with a history of acute coronary syndrome within the recent 6 months; Acute coronary syndrome refers to acute cardiac ischemic syndrome caused by rupture or erosion of unstable atherosclerotic plaques in the coronary artery and fresh thrombosis, including ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina pectoris
- Patients with transient ischemic attack (TIA) or ischemic/hemorrhagic stroke within the recent 3 months
- Patients with severe pulmonary insufficiency who cannot tolerate general anesthesia
- Patients with abnormal liver and kidney function before operation [alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 times the upper limit of normal value; Serum creatinine (Cr) >150umol/L]
- Patients with thoracoabdominal aortic dissection
- Patients with occluded superior mesenteric artery, celiac trunk artery, or renal artery
- Patients requiring simultaneous coverage or embolization of bilateral internal iliac arteries
- Patients with severe stenosis, calcification or mural thrombus at stent-graft landing zone, and this situation leads to difficulty in adhering the covered stent or affecting the patency of the stent
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 80 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Németország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study is designed as a single-center, prospective, single-arm, open-label, exploratory study. The objective is to evaluate the feasibility of Thoracoabdominal Artery Stent Graft System for endovascular treatment of Thoracoabdominal aortic aneurysms (TAAA).
A vizsgálat csoportja
- Endovascular therapy used as treatment of TAAAA vizsgált kezelés
Traditional methods of treatment of TAAA include open surgery and hybrid surgery. Open surgery requires Thoracoabdominal incision which will result in a huge wound and the reconstruction of the visceral artery is also complicated. endovascular therapy has been developed for many years and has demonstrated significant advantages, such as small wounds, and fewer complications. Now Endovascular therapy is gradually used in the treatment of TAAA as well. Compared with traditional open surgery and hybrid surgery, the risk-benefit ratio of endovascular therapy is much better. When the risk-benefit gap between the investigational device and existing treatments is so wide that a control group is ethically unfeasible. So a single-arm exploratory study is adopted.
Kezelés: The system includes the G-Branch™ thoracoabdominal aortic stent graft system, the peripheral vascular stent graft system, and the aortic extension stent graft system
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Exploratory Study of Thoracoabdominal Artery Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysms
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT06710938: ki vehet részt
- A regiszteradat frissítve
- 2026. május 26.